References
1. van Winkelhoff AJ, Carlee AW, de Graaff J. Bacteroides endodontalis and other black-pigmented Bacteroides species in odontogenic abscesses. Infect Immun 1985. 49(3)494–497.
2. Seltzer S, Farber PA. Microbiologic factors in endodontology. Oral Surg Oral Med Oral Pathol 1994. 78(5)634–645.
3. van Steenbergen TJM, van Winkelhoff AJ, Mayrand D, Grenier D, De Graaff J. Bacteroides endodontalis sp. nov., an asaccharolytic black-pigmented Bacteroides species from infected dental root canals. Int J Syst Bacteriol 1984. 34(2)118–120.
4. Hashioka K, Yamasaki M, Nakane A, Horiba N, Nakamura H. The relationship between clinical symptoms and anaerobic bacteria from infected root canals. J Endod 1992. 18(11)558–561.
5. Machado de Oliveira JC, Siqueira JF, Alves GB, Hirata R, Andrade AFB. Detection of Porphyromonas endodontalis in infected root canals by 16S rRNA gene-directed polymerase chain reaction. J Endod 2000. 26(12)729–732.
6. van Winkelhoff AJ, van Steenbergen TJ, Kippuw N, De Graaff J. Further characterization of Bacteroides endodontalis, an asaccharolytic black-pigmented Bacteroides species from the oral S cavity. J Clin Microbiol 1985. 22(1)75–79.
7. Tanner AC, Paster BJ, Lu SC, Kanasi E, Kent R Jr, Van Dyke T, Sonis ST. Subgingival and tongue microbiota during early periodontitis. J Dent Res 2006. 85(4)318–323.
8. Kumar PS, Griffen AL, Barton JA, Paster BJ, Moeschberger ML, Leys EJ. New bacterial species associated with chronic periodontitis. J Dent Res 2003. 82(5)338–344.
9. Dahlén G, Leonhardt A. A new checkerboard panel for testing bacterial markers in periodontal disease. Oral Microbiol Immunol 2006. 21(1)6–11.
10. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999. 340(2)115–126.
11. Lüscher TF, Barton M. Biology of the endothelium. Clin Cardiol 1997. 2011 Suppl 2. II3–II10.
12. Kinlay S, Libby P, Ganz P. Endothelial function and coronary artery disease. Curr Opin Lipidol 2001. 12(4)383–389.
13. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation 2004. 10921 suppl 1. II2–II10.
14. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002. 105(9)1135–1143.
15. Lusis AJ. Atherosclerosis. Nature 2000. 407(6801)233–241.
16. Libby P. Inflammation in atherosclerosis. Nature 2002. 420(6917)868–874.
17. Saikku P, Leinonen M, Tenkanen L, Linnanmäki E, Ekman MR, Manninen V, Mänttäri M, Frick MH, Huttunen JK. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992. 116(4)273–278.
18. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994. 71(5)437–439.
19. Hajjar DP, Fabricant CG, Minick CR, Fabricant J. Virus-induced atherosclerosis. Herpesvirus infection alters aortic cholesterol metabolism and accumulation. Am J Pathol 1986. 122(1)62–70.
20. Epstein SE, Zhu J, Burnett MS, Zhou YF, Vercellotti G, Hajjar D. Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol 2000. 20(6)1417–1420.
21. Epstein SE. The multiple mechanisms by which infection may contribute to atherosclerosis development and course. Circ Res 2002. 90(1)2–4.
22. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Rippin G, Victor A, Hafner G, Schlumberger W, Meyer J. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 2002. 105(1)15–21.
23. Mattila KJ, Nieminen MS, Valtonen VV, Rasi VP, Kesäniemi YA, Syrjälä SL, Jungell PS, Isoluoma M, Hietaniemi K, Jokinen MJ. Association between dental health and acute myocardial infarction. BMJ 1989. 298(6676)779–781.
24. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol 1996. 6710 suppl. 1123–1137.
25. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J Periodontol 2000. 71(10)1554–1560.
26. Spahr A, Klein E, Khuseyinova N, Boeckh C, Muche R, Kunze M, Rothenbacher D, Pezeshki G, Hoffmeister A, Koenig W. Periodontal infections and coronary heart disease: role of periodontal bacteria and importance of total pathogen burden in the Coronary Event and Periodontal Disease (CORODONT) study. Arch Intern Med 2006. 166(5)554–559.
27. Deshpande RG, Khan MB, Genco CA. Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect Immun 1998. 66(11)5337–5343.
28. Dorn BR, Dunn WA Jr, Progulske-Fox A. Invasion of human coronary artery cells by periodontal pathogens. Infect Immun 1999. 67(11)5792–5798.
29. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993. 362(6423)801–809.
30. Paster BJ, Dewhirst FE, Olsen I, Fraser GJ. Phylogeny of Bacteroides, Prevotella, and Porphyromonas spp. and related bacteria. J Bacteriol 1994. 176(3)725–732.
31. Dorn BR, Harris LJ, Wujick CT, Vertucci FJ, Progulske-Fox A. Invasion of vascular cells in vitro by Porphyromonas endodontalis. Int Endod J 2002. 35(4)366–371.
32. Gibbons RJ. Bacterial adhesion to oral tissues: a model for infectious diseases. J Dent Res 1989. 68(5)750–760.
33. Falkow S. Bacterial entry into eukaryotic cells. Cell 1991. 65(7)1099–1102.
34. Pearce E, Tregouet DA, Samnegård A, Morgan AR, Cox C, Hamsten A, Eriksson P, Ye S. Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction. Circ Res 2005. 97(10)1070–1076.
35. Presta M, Camozzi M, Salvatori G, Rusnati M. Role of the soluble pattern recognition receptor PTX3 in vascular biology. J Cell Mol Med 2007. 11(4)723–738.
36. Lee YW, Eum SY, Chen KC, Hennig B, Toborek M. Gene expression profile in interleukin-4-stimulated human vascular endothelial cells. Mol Med 2004. 10(1-6)19–27.
37. Ito T, Ikeda U. Inflammatory cytokines and cardiovascular disease. Curr Drug Targets Inflamm Allergy 2003. 2(3)257–265.
38. Chou HH, Yumoto H, Davey M, Takahashi Y, Miyamoto T, Gibson FC 3rd, Genco CA. Porphyromonas gingivalis fimbria-dependent activation of inflammatory genes in human aortic endothelial cells. Infect Immun 2005. 73(9)5367–5378.
39. Gagarin D, Yang Z, Butler J, Wimmer M, Du B, Cahan P, McCaffrey TA. Genomic profiling of acquired resistance to apoptosis in cells derived from human atherosclerotic lesions: potential role of STATs, cyclinD1, BAD, and Bcl-XL. J Mol Cell Cardiol 2005. 39(3)453–465.
40. Fan T, Lu H, Hu H, Shi L, McClarty GA, Nance DM, Greenberg AH, Zhong G. Inhibition of apoptosis in Chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J Exp Med 1998. 187(4)487–496.
41. Zhu H, Shen Y, Shenk T. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J Virol 1995. 69(12)7960–7970.
42. Grütter MG. Caspases: key players in programmed cell death. Curr Opin Struct Biol 2000. 10(6)649–655.
43. Xu G, Gong Z, Yu W, Gao L, He S, Qian Z. Increased expression ratio of Bcl-2/Bax is associated with crocin-mediated apoptosis in bovine aortic endothelial cells. Basic Clin Pharmacol Toxicol 2007. 100(1)31–35.
44. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998. 281(5381)1322–1326.
45. Toutouzas K, Androulakis G, Chatzigianni E, Davaris PS, Karayannis M, Konstadoulakis MM, Messaris E. Expression of c-myc and H-ras and absence of expression of p53 and bcl-2 genes in atherosclerotic human carotid arteries. J Clin Basic Cardiol 2002. 5(3)253–256.
46. Dimmeler S, Breitschopf K, Haendeler J, Zeiher AM. Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. J Exp Med 1999. 189(11)1815–1822.
47. Jung IK, Kim DM, Kim BY, Kim YG, Kim IJ, Kim TH, Park JY, Son SM, Yoo HJ, Lee MK, Lee BY, Lee IK, Cha BY. NF-kB and atherosclerosis. Biowave 2007. 9(7)1–13.
48. Esemuede N, Lee T, Pierre-Paul D, Sumpio BE, Gahtan V. The role of thrombospondin-1 in human disease. J Surg Res 2004. 122(1)135–142.
49. Vischer UM. von Willebrand factor, endothelial dysfunction, and cardiovascular disease. J Thromb Haemost 2006. 4(6)1186–1193.
50. Dadgostar H, Zarnegar B, Hoffmann A, Qin XF, Truong U, Rao G, Baltimore D, Cheng G. Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes. Proc Natl Acad Sci USA 2002. 99(3)1497–1502.
51. Mach F, Schönbeck U, Libby P. CD40 signaling in vascular cells: a key role in atherosclerosis? Atherosclerosis 1998. 137suppl. S89–S95.
52. Xu Q. Role of heat shock proteins in atherosclerosis. Arterioscler Thromb Vasc Biol 2002. 22(10)1547–1559.
53. Haskard DO, Boyle JJ, Mason JC. The role of complement in atherosclerosis. Curr Opin Lipidol 2008. 19(5)478–482.